Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
8.07
+0.17 (2.15%)
At close: Jan 21, 2026, 4:00 PM EST
8.07
0.00 (0.00%)
After-hours: Jan 21, 2026, 4:04 PM EST
Adicet Bio Employees
Adicet Bio had 152 employees as of December 31, 2024. The number of employees increased by 9 or 6.29% compared to the previous year.
Employees
152
Change (1Y)
9
Growth (1Y)
6.29%
Revenue / Employee
n/a
Profits / Employee
-$756,671
Market Cap
81.56M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 152 | 9 | 6.29% | 152 | 0 |
| Dec 31, 2023 | 143 | 11 | 8.33% | 143 | 0 |
| Dec 31, 2022 | 132 | 46 | 53.49% | 132 | 0 |
| Dec 31, 2021 | 86 | 4 | 4.88% | 86 | 0 |
| Dec 31, 2020 | 82 | 13 | 18.84% | 81 | 1 |
| Jun 30, 2020 | 70 | - | - | 69 | 1 |
| Mar 31, 2020 | 69 | - | - | 68 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pliant Therapeutics | 171 |
| Korro Bio | 104 |
| XBiotech | 92 |
| Immunic | 91 |
| Gain Therapeutics | 25 |
| Spruce Biosciences | 21 |
| Atossa Therapeutics | 15 |
| CalciMedica | 14 |
ACET News
- 14 days ago - Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones - Business Wire
- 26 days ago - Adicet Bio Announces Reverse Stock Split - Business Wire
- 7 weeks ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates - Business Wire
- 2 months ago - Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference - Business Wire
- 3 months ago - Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA) - Business Wire
- 3 months ago - Adicet Bio, Inc. - Special Call - Seeking Alpha